Clinical Trials Directory

Trials / Completed

CompletedNCT00442585

S(+)-Ibuprofen Effects on Asprin Treated Volunteers

Double Blind, Randomised, Parallel Group, Placebo Controlled Clinical Trial of S(+)-Ibuprofen Effects on TxB2 Concentrations and Platelet Aggregation in Aspirin-treated Healthy Adult Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
72 (planned)
Sponsor
Gebro Pharma GmbH · Industry
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this clinical trial is to determine whether S(+)-ibuprofen affect the platelet inhibition under steady state acetylsalicylic acid conditions.

Conditions

Interventions

TypeNameDescription
DRUGS(+)-ibuprofen

Timeline

Start date
2006-09-01
Completion
2007-10-01
First posted
2007-03-02
Last updated
2012-03-13

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT00442585. Inclusion in this directory is not an endorsement.

S(+)-Ibuprofen Effects on Asprin Treated Volunteers (NCT00442585) · Clinical Trials Directory